Substance list · California

Suggested substance list (page 2)

Entries
1015
Version date
2026-07-31

Entries 501 to 1000 of 1015

SubstanceEnglish nameCAS TypeCategoryThreshold ConditionsValid
Herbal remedies containing plant species of the genus AristolochiaHerbal remedies containing plant species of the genus Aristolochia othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2004-07-09 | CAS column: "---"
HexachlorobenzeneHexachlorobenzene118-74-1 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
HexachlorobenzeneHexachlorobenzene118-74-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
HexachlorobutadieneHexachlorobutadiene87-68-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-05-03
Hexachlorocyclohexane (technical grade)Hexachlorocyclohexane (technical grade) othercancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---"
Hexachlorocyclohexane (alpha isomer)Hexachlorocyclohexane (alpha isomer) othercancer 0.3 µg/day (NSRL or MADL) Sub entry under "Hexachlorocyclohexane (technical grade)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Hexachlorocyclohexane (beta isomer)Hexachlorocyclohexane (beta isomer) othercancer 0.5 µg/day (NSRL or MADL) Sub entry under "Hexachlorocyclohexane (technical grade)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Hexachlorocyclohexane (gamma isomer)Hexachlorocyclohexane (gamma isomer) othercancer 0.6 µg/day (NSRL or MADL) Sub entry under "Hexachlorocyclohexane (technical grade)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
HexachlorodibenzodioxinHexachlorodibenzodioxin34465-46- 8 substancecancer 0.0002 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
HexachloroethaneHexachloroethane67-72-1 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer)2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer) othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2005-03-04 | CAS column: "---"
Hexafluoroacetone [Basis for listing changed effective June 6, 2014]Hexafluoroacetone [Basis for listing changed effective June 6, 2014]684-16-2 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: LC SQE; Date listed: 2008-08-01
HexamethylphosphoramideHexamethylphosphoramide680-31-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
HexamethylphosphoramideHexamethylphosphoramide680-31-9 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
n-Hexanen-Hexane110-54-3 substancemale 28,000 (oral) 20,000 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2017-12-15
2,5-Hexanedione2,5-Hexanedione110-13-4 substancemale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2015-12-04
Histrelin acetateHistrelin acetate otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15 | CAS column: "---"
HydramethylnonHydramethylnon67485-29-4 substancedevelopmental, male 120 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-05
HydrazineHydrazine302-01-2 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Hydrazine sulfateHydrazine sulfate10034-93-2 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Hydrazobenzene (1,2-Diphenylhydrazine)Hydrazobenzene (1,2-Diphenylhydrazine)122-66-7 substancecancer 0.8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
HydrochlorothiazideHydrochlorothiazide58-93-5; 125727-50-6; 8049-49-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2026-07-17
Hydrogen cyanide (HCN) and cyanide salts (CN salts)Hydrogen cyanide (HCN) and cyanide salts (CN salts) groupmale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2013-07-05 | CAS column: "---"
Cyanide salts that readily dissociate in solution (expressed as cyanide)Cyanide salts that readily dissociate in solution (expressed as cyanide) groupmale 9.8 µg/day (NSRL or MADL) Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013.
Hydrogen cyanideHydrogen cyanide othermale 10 (oral) µg/day (NSRL or MADL) Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013.
Sodium cyanideSodium cyanide othermale 19 (oral) µg/day (NSRL or MADL) Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013.
Potassium cyanidePotassium cyanide othermale 25 (oral) µg/day (NSRL or MADL) Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013.
1-Hydroxyanthraquinone1-Hydroxyanthraquinone129-43-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2005-05-27
HydroxyureaHydroxyurea127-07-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-05-01
Idarubicin hydrochlorideIdarubicin hydrochloride57852-57-0 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
IfosfamideIfosfamide3778-73-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Iodine-131Iodine-13110043-66-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
ImazalilImazalil35554-44-0 substancecancer 11 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-05-20
Indeno[1,2,3-cd]pyreneIndeno[1,2,3-cd]pyrene193-39-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Indium phosphideIndium phosphide22398-80-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-02-27
Indium tin oxideIndium tin oxide50926-11-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2021-03-19
IQ (2-Amino-3-methylimidazo[4,5-f] quinoline)IQ (2-Amino-3-methylimidazo[4,5-f] quinoline)76180-96-6 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-04-01
IprodioneIprodione36734-19-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
IprovalicarbIprovalicarb140923-17-7/ 140923-25-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2007-06-01
Iron dextran complexIron dextran complex9004-66-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Isobutyl nitriteIsobutyl nitrite542-56-3 substancecancer 7.4 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
IsopreneIsoprene78-79-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
IsopyrazamIsopyrazam881685-58-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2012-07-24
IsosafroleIsosafrole120-58-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: December 8, 2006 until 2006-12-08
IsotretinoinIsotretinoin4759-48-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
IsoxaflutoleIsoxaflutole141112-29-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-12-22
Kresoxim-methylKresoxim-methyl143390-89-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2012-02-03
LactofenLactofen77501-63-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
LasiocarpineLasiocarpine303-34-4 substancecancer 0.09 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Lead [Basis for listing changed effective November 22, 2013]Lead [Basis for listing changed effective November 22, 2013] otherdevelopmental, female, male 0.5 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-02-27 | CAS column: "---"
Lead and lead compoundsLead and lead compounds groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-10-01 | CAS column: "---"
LeadLead othercancer 15 (oral) µg/day (NSRL or MADL) Sub entry under "Lead and lead compounds" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Lead acetateLead acetate301-04-2 substancecancer 23 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Lead phosphateLead phosphate7446-27-7 substancecancer 58 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Lead subacetateLead subacetate1335-32-6 substancecancer 41 (oral) µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Leather dustLeather dust othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-04-29 | CAS column: "---"
Leucomalachite greenLeucomalachite green129-73-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-04-21
Leuprolide acetateLeuprolide acetate74381-53-6 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
LevodopaLevodopa59-92-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
Levonorgestrel implantsLevonorgestrel implants797-63-7 substancefemale µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
Lindane and other hexachlorocyclohexane isomersLindane and other hexachlorocyclohexane isomers groupcancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---"
LinuronLinuron330-55-2 substancedevelopmental 460 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-19
Lithium carbonateLithium carbonate554-13-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
Lithium citrateLithium citrate919-16-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
LorazepamLorazepam846-49-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
LovastatinLovastatin75330-75-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
LynestrenolLynestrenol52-76-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-02-27
MalathionMalathion121-75-5 substancecancer 180 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2016-05-20
Malonaldehyde, sodium saltMalonaldehyde, sodium salt24382-04-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-05-03
MancozebMancozeb8018-01-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
ManebManeb12427-38-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Marijuana smokeMarijuana smoke othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2009-06-19 | CAS column: "---"
Me-A-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole)Me-A-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole)68006-83-7 substancecancer 0.6 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
MebendazoleMebendazole31431-39-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
Medroxyprogesterone acetateMedroxyprogesterone acetate71-58-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Medroxyprogesterone acetateMedroxyprogesterone acetate71-58-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Megestrol acetateMegestrol acetate595-33-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2014-03-28
Megestrol acetateMegestrol acetate595-33-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline)MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline)77094-11-2 substancecancer 0.46 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline)MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline)77500-04-0 substancecancer 0.41 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
MelphalanMelphalan148-82-3 substancecancer 0.005 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
MelphalanMelphalan148-82-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
MenotropinsMenotropins9002-68-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
MepanipyrimMepanipyrim110235-47-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-07-01
MeprobamateMeprobamate57-53-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
2‑Mercaptobenzothiazole2‑Mercaptobenzothiazole149-30-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2017-10-27
MercaptopurineMercaptopurine6112-76-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Mercury and mercury compoundsMercury and mercury compounds groupdevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01 | CAS column: "---"
MerphalanMerphalan531-76-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
MestranolMestranol72-33-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Metam potassiumMetam potassium137-41-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-12-31
Methacycline hydrochlorideMethacycline hydrochloride3963-95-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
Metham sodiumMetham sodium137-42-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
Metham sodiumMetham sodium137-42-8 substancedevelopmental 290 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
MethanolMethanol67-56-1 substancedevelopmental 47,000 (inhalation) 23,000 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2012-03-16
MethazoleMethazole20354-26-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-12-01
MethimazoleMethimazole60-56-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
MethotrexateMethotrexate59-05-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Methotrexate sodiumMethotrexate sodium15475-56-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
5-Methoxypsoralen with ultraviolet A therapy5-Methoxypsoralen with ultraviolet A therapy484-20-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
8-Methoxypsoralen with ultraviolet A therapy8-Methoxypsoralen with ultraviolet A therapy298-81-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Methyl acrylateMethyl acrylate96-33-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2021-12-17
2-Methylaziridine (Propyleneimine)2-Methylaziridine (Propyleneimine)75-55-8 substancecancer 0.028 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
MethylazoxymethanolMethylazoxymethanol590-96-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Methylazoxymethanol acetateMethylazoxymethanol acetate592-62-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Methyl bromide, as a structural fumigantMethyl bromide, as a structural fumigant74-83-9 substancedevelopmental 810 (inhalation) µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1993-01-01
Methyl carbamateMethyl carbamate598-55-0 substancecancer 160 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Methyl chlorideMethyl chloride74-87-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-03-10
Methyl chloride [Basis for listing changed effective March 7, 2014]Methyl chloride [Basis for listing changed effective March 7, 2014]74-87-3 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2009-08-07
3-Methylcholanthrene3-Methylcholanthrene56-49-5 substancecancer 0.03 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
5-Methylchrysene5-Methylchrysene3697-24-3 substancecancer 0.0084 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
4,4'-Methylene bis(2-chloroaniline)4,4'-Methylene bis(2-chloroaniline)101-14-4 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
4,4'-Methylene bis(N,N-dimethyl)benzenamine4,4'-Methylene bis(N,N-dimethyl)benzenamine101-61-1 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
4,4'-Methylene bis(2-methylaniline)4,4'-Methylene bis(2-methylaniline)838-88-0 substancecancer 0.8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
4,4'-Methylenedianiline4,4'-Methylenedianiline101-77-9 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
4,4'-Methylenedianiline dihydrochloride4,4'-Methylenedianiline dihydrochloride13552-44-8 substancecancer 0.6 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
MethyleugenolMethyleugenol93-15-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-11-16
Methylhydrazine and its saltsMethylhydrazine and its salts groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-07-01 | CAS column: "---"
MethylhydrazineMethylhydrazine othercancer 0.058 (oral) 0.090 (inhalation) µg/day (NSRL or MADL) Sub entry under "Methylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Methylhydrazine sulfateMethylhydrazine sulfate othercancer 0.18 µg/day (NSRL or MADL) Sub entry under "Methylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
2-Methylimidazole2-Methylimidazole693-98-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-06-22
4-Methylimidazole4-Methylimidazole822-36-6 substancecancer 29 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-01-07
Methyl iodideMethyl iodide74-88-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Methyl isobutyl ketoneMethyl isobutyl ketone108-10-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-11-04
Methyl isobutyl ketone (MIBK)Methyl isobutyl ketone (MIBK)108-10-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2014-03-28
Methyl isocyanate (MIC)Methyl isocyanate (MIC)624-83-9 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2010-11-12
Methyl isopropyl ketoneMethyl isopropyl ketone563-80-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-02-17 | Delisted: April 4, 2014 until 2014-04-04
Methyl mercuryMethyl mercury otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01 | CAS column: "---"
Methylmercury compoundsMethylmercury compounds groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01 | CAS column: "---"
Methyl methanesulfonateMethyl methanesulfonate66-27-3 substancecancer 7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Methyl-n-butyl ketoneMethyl-n-butyl ketone591-78-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2015-12-04
Methyl-n-butyl ketone [Basis for listing changed effective November 9, 2015]Methyl-n-butyl ketone [Basis for listing changed effective November 9, 2015]591-78-6 substancemale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2009-08-07
2-Methyl-1-nitroanthraquinone (of uncertain purity)2-Methyl-1-nitroanthraquinone (of uncertain purity)129-15-7 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
N-Methyl-N-FormylhydrazineN-Methyl-N-Formylhydrazine758-17-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2025-12-08
N-Methyl-N'-nitro-N-nitrosoguanidineN-Methyl-N'-nitro-N-nitrosoguanidine70-25-7 substancecancer 0.08 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
N-MethylolacrylamideN-Methylolacrylamide924-42-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
N-MethylpyrrolidoneN-Methylpyrrolidone872-50-4 substancedevelopmental 3200 (inhalation) 17000 (dermal) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-06-15
α-Methyl styrene (alpha-Methylstyrene)α-Methyl styrene (alpha-Methylstyrene)98-83-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-11-02
α-Methyl styreneα-Methyl styrene98-83-9 substancefemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-07-29 | Delisted: April 4, 2014 until 2014-04-04
MethyltestosteroneMethyltestosterone58-18-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
MethylthiouracilMethylthiouracil56-04-2 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
MetiramMetiram9006-42-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
MetiramMetiram9006-42-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
MetronidazoleMetronidazole443-48-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Michler's ketoneMichler's ketone90-94-8 substancecancer 0.8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Midazolam hydrochlorideMidazolam hydrochloride59467-96-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Minocycline hydrochloride (internal use)Minocycline hydrochloride (internal use)13614-98-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
MirexMirex2385-85-5 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
MisoprostolMisoprostol59122-46-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Mitomycin CMitomycin C50-07-7 substancecancer 0.00009 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Mitoxantrone hydrochlorideMitoxantrone hydrochloride70476-82-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2015-01-23
Mitoxantrone hydrochlorideMitoxantrone hydrochloride70476-82-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
MolinateMolinate2212-67-1 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2009-12-11
Molybdenum trioxideMolybdenum trioxide1313-27-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2021-03-19
MON 4660 (dichloroacetyl-1-oxa-4-azaspiro(4,5)-decaneMON 4660 (dichloroacetyl-1-oxa-4-azaspiro(4,5)-decane71526-07-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-03-22
MON 13900 (furilazole)MON 13900 (furilazole)121776-33-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-03-22
3-Monochloropropane-1,2-diol (3-MCPD)3-Monochloropropane-1,2-diol (3-MCPD)96-24-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2010-10-08
MonocrotalineMonocrotaline315-22-0 substancecancer 0.07 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture)MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture)113803-47-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-11-04
5-(Morpholinomethyl)-3-[(5-nitrofurfuryl-idene)-amino]-2-oxazolidinone5-(Morpholinomethyl)-3-[(5-nitrofurfuryl-idene)-amino]-2-oxazolidinone139-91-3 substancecancer 0.18 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Mustard GasMustard Gas505-60-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
MX (3-chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone)MX (3-chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone)77439-76-0 substancecancer 0.11 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2000-12-22
MyclobutanilMyclobutanil88671-89-0 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-04-16
beta-Myrcenebeta-Myrcene123-35-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2015-03-27
NabamNabam142-59-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
Nafarelin acetateNafarelin acetate86220-42-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
NafenopinNafenopin3771-19-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Nalidixic acidNalidixic acid389-08-2 substancecancer 28 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
NaphthaleneNaphthalene91-20-3 substancecancer 5.8 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2002-04-19
1-Naphthylamine1-Naphthylamine134-32-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
2-Naphthylamine2-Naphthylamine91-59-8 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Neomycin sulfate (internal use)Neomycin sulfate (internal use)1405-10-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
Netilmicin sulfateNetilmicin sulfate56391-57-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Nickel (Metallic)Nickel (Metallic)7440-02-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Nickel acetateNickel acetate373-02-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Nickel carbonateNickel carbonate3333-67-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Nickel carbonylNickel carbonyl13463-39-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
Nickel carbonylNickel carbonyl13463-39-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-09-01
Nickel compoundsNickel compounds groupcancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2004-05-07 | CAS column: "---"
Nickel (soluble compounds)Nickel (soluble compounds) groupdevelopmental, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2018-10-26 | CAS column: "---"
Nickel hydroxideNickel hydroxide12054-48-7; 12125-56-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
NickeloceneNickelocene1271-28-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Nickel oxideNickel oxide1313-99-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Nickel refinery dust from the pyrometallurgical processNickel refinery dust from the pyrometallurgical process othercancer 0.8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---"
Nickel subsulfideNickel subsulfide12035-72-2 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
NicotineNicotine54-11-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
NifedipineNifedipine21829-25-4 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
NimodipineNimodipine66085-59-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-04-24
NiridazoleNiridazole61-57-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Nitrapyrin [Basis for listing changed effective on November 4, 2015]Nitrapyrin [Basis for listing changed effective on November 4, 2015]1929-82-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2005-10-05
NitrapyrinNitrapyrin1929-82-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
Nitrilotriacetic acidNitrilotriacetic acid139-13-9 substancecancer 100 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Nitrilotriacetic acid, trisodium salt monohydrateNitrilotriacetic acid, trisodium salt monohydrate18662-53-8 substancecancer 70 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-04-01
5-Nitroacenaphthene5-Nitroacenaphthene602-87-9 substancecancer 6 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
5-Nitro-o-anisidine5-Nitro-o-anisidine99-59-2 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: December 8, 2006 until 2006-12-08
o-Nitroanisoleo-Nitroanisole91-23-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-10-01
para-Nitroanisolepara-Nitroanisole100-17-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2019-09-13
NitrobenzeneNitrobenzene98-95-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-08-26
NitrobenzeneNitrobenzene98-95-3 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-03-30
4-Nitrobiphenyl4-Nitrobiphenyl92-93-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
6-Nitrochrysene6-Nitrochrysene7496-02-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
Nitrofen (technical grade)Nitrofen (technical grade)1836-75-5 substancecancer 9 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
2-Nitrofluorene2-Nitrofluorene607-57-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
NitrofurantoinNitrofurantoin67-20-9 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1991-04-01
NitrofurazoneNitrofurazone59-87-0 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
1-[(5-Nitrofurfurylidene)-amino]-2-imidazolidinone1-[(5-Nitrofurfurylidene)-amino]-2-imidazolidinone555-84-0 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamideN-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide531-82-8 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Nitrogen mustard (Mechlorethamine)Nitrogen mustard (Mechlorethamine)51-75-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Nitrogen mustard (Mechlorethamine)Nitrogen mustard (Mechlorethamine)51-75-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride)Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride)55-86-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride)Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride)55-86-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Nitrogen mustard N-oxideNitrogen mustard N-oxide126-85-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Nitrogen mustard N-oxide hydrochlorideNitrogen mustard N-oxide hydrochloride302-70-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
NitromethaneNitromethane75-52-5 substancecancer 39 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-05-01
2-Nitropropane2-Nitropropane79-46-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
1-Nitropyrene1-Nitropyrene5522-43-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
4-Nitropyrene4-Nitropyrene57835-92-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
N-Nitrosodi-n-butylamineN-Nitrosodi-n-butylamine924-16-3 substancecancer 0.06 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
N-NitrosodiethanolamineN-Nitrosodiethanolamine1116-54-7 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-NitrosodiethylamineN-Nitrosodiethylamine55-18-5 substancecancer 0.02 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
N-NitrosodimethylamineN-Nitrosodimethylamine62-75-9 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
p-Nitrosodiphenylaminep-Nitrosodiphenylamine156-10-5 substancecancer 30 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-NitrosodiphenylamineN-Nitrosodiphenylamine86-30-6 substancecancer 80 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
N-Nitrosodi-n-propylamineN-Nitrosodi-n-propylamine621-64-7 substancecancer 0.1 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-Nitroso-N-ethylureaN-Nitroso-N-ethylurea759-73-9 substancecancer 0.03 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
N-NitrosohexamethyleneimineN-Nitrosohexamethyleneimine932-83-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2018-11-23
3-(N-Nitrosomethylamino) propionitrile3-(N-Nitrosomethylamino) propionitrile60153-49-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-04-01
4-(N-Nitrosomethylamino)-1-(3-pyridyl)1-butanone4-(N-Nitrosomethylamino)-1-(3-pyridyl)1-butanone64091-91-4 substancecancer 0.014 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-04-01
N-Nitrosomethyl-n-butylamineN-Nitrosomethyl-n-butylamine7068-83-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-decylamineN-Nitrosomethyl-n-decylamine75881-22-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-dodecylamineN-Nitrosomethyl-n-dodecylamine55090-44-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-NitrosomethylethylamineN-Nitrosomethylethylamine10595-95-6 substancecancer 0.03 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
N-Nitrosomethyl-n-heptylamineN-Nitrosomethyl-n-heptylamine16338-99-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-hexylamineN-Nitrosomethyl-n-hexylamine28538-70-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-nonylamineN-Nitrosomethyl-n-nonylamine75881-19-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-octylamineN-Nitrosomethyl-n-octylamine34423-54-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-pentylamineN-Nitrosomethyl-n-pentylamine13256-07-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-propylamineN-Nitrosomethyl-n-propylamine924-46-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-tetradecylamineN-Nitrosomethyl-n-tetradecylamine75881-20-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitrosomethyl-n-undecylamineN-Nitrosomethyl-n-undecylamine68107-26-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
N-Nitroso-N-methylureaN-Nitroso-N-methylurea684-93-5 substancecancer 0.006 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
N-Nitroso-N-methylurethaneN-Nitroso-N-methylurethane615-53-2 substancecancer 0.006 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
N-NitrosomethylvinylamineN-Nitrosomethylvinylamine4549-40-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-NitrosomorpholineN-Nitrosomorpholine59-89-2 substancecancer 0.1 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-NitrosonornicotineN-Nitrosonornicotine16543-55-8 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-NitrosopiperidineN-Nitrosopiperidine100-75-4 substancecancer 0.07 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N-NitrosopyrrolidineN-Nitrosopyrrolidine930-55-2 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
N-NitrososarcosineN-Nitrososarcosine13256-22-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
o-Nitrotolueneo-Nitrotoluene88-72-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Nitrous oxide [Basis for listing changed effective November 8, 2013]Nitrous oxide [Basis for listing changed effective November 8, 2013]10024-97-2 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-08-01
Norethisterone (Norethindrone)Norethisterone (Norethindrone)68-22-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Norethisterone (Norethindrone)Norethisterone (Norethindrone)68-22-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Norethisterone acetate (Norethindrone acetate)Norethisterone acetate (Norethindrone acetate)51-98-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-10-01
Norethisterone (Norethindrone) /Ethinyl estradiolNorethisterone (Norethindrone) /Ethinyl estradiol68-22-4/ 57-63-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Norethisterone (Norethindrone) /MestranolNorethisterone (Norethindrone) /Mestranol68-22-4/ 72-33-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
NorethynodrelNorethynodrel68-23-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-02-27
NorgestrelNorgestrel6533-00-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Ochratoxin AOchratoxin A303-47-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
Oil Orange SSOil Orange SS2646-17-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Oral contraceptives, combinedOral contraceptives, combined othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---"
Oral contraceptives, sequentialOral contraceptives, sequential othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---"
OryzalinOryzalin19044-88-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-09-12
OxadiazonOxadiazon19666-30-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1991-07-01
OxadiazonOxadiazon19666-30-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
OxazepamOxazepam604-75-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
OxazepamOxazepam604-75-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
p,p'-Oxybis(benzenesulfonyl hydrazide)p,p'-Oxybis(benzenesulfonyl hydrazide)80-51-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: December 13, 2013 until 2013-12-13
Oxydemeton methylOxydemeton methyl301-12-2 substancefemale, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
OxymetholoneOxymetholone434-07-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
OxymetholoneOxymetholone434-07-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-05-01
Oxytetracycline (internal use)Oxytetracycline (internal use)79-57-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
Oxytetracycline hydrochloride (internal use)Oxytetracycline hydrochloride (internal use)2058-46-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-10-01
Oxythioquinox (Chinomethionat)Oxythioquinox (Chinomethionat)2439-01-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20
Oxythioquinox (Chinomethionat)Oxythioquinox (Chinomethionat)2439-01-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
PaclitaxelPaclitaxel33069-62-4 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
Palygorskite fibers (> 5µm in length)Palygorskite fibers (> 5µm in length)12174-11-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-12-28
Panfuran SPanfuran S794-93-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
ParamethadioneParamethadione115-67-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
ParathionParathion56-38-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2016-05-20
PenicillaminePenicillamine52-67-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
pentabromodiphenyl ether mixture [DE-71 (technical grade)]pentabromodiphenyl ether mixture [DE-71 (technical grade)] groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2017-07-07 | CAS column: "---"
PentachlorophenolPentachlorophenol87-86-5 substancecancer 40 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Pentachlorophenol and by-products of its synthesis (complex mixture)Pentachlorophenol and by-products of its synthesis (complex mixture) groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-10-21 | CAS column: "---"
Pentobarbital sodiumPentobarbital sodium57-33-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Pentosan polysulfate sodiumPentosan polysulfate sodium othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2014-04-18 | CAS column: "---"
PentostatinPentostatin53910-25-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
Perfluorononanoic acid (PFNA) and its saltsPerfluorononanoic acid (PFNA) and its salts groupmale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2021-12-31 | CAS column: "---"
Perfluorooctane sulfonate (PFOS)Perfluorooctane sulfonate (PFOS)1763-23-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2017-11-10
Perfluorooctane sulfonic acid (PFOS) and its salts and transformation and degradation precursorsPerfluorooctane sulfonic acid (PFOS) and its salts and transformation and degradation precursors groupcancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2021-12-24 | CAS column: "---"
Perfluorooctanoic acid (PFOA)Perfluorooctanoic acid (PFOA)335-67-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2022-02-25
Perfluorooctanoic acid (PFOA)Perfluorooctanoic acid (PFOA)335-67-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2017-11-10
PertuzumabPertuzumab380610-27-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2017-01-27
PhenacemidePhenacemide63-98-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
PhenacetinPhenacetin62-44-2 substancecancer 300 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
PhenazopyridinePhenazopyridine94-78-0 substancecancer 4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Phenazopyridine hydrochloridePhenazopyridine hydrochloride136-40-3 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
PhenesterinPhenesterin3546-10-9 substancecancer 0.005 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
PhenobarbitalPhenobarbital50-06-6 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
PhenolphthaleinPhenolphthalein77-09-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
PhenoxybenzaminePhenoxybenzamine59-96-1 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Phenoxybenzamine hydrochloridePhenoxybenzamine hydrochloride63-92-3 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
PhenprocoumonPhenprocoumon435-97-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
o-Phenylenediamine and its saltso-Phenylenediamine and its salts95-54-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
o-Phenylenediamineo-Phenylenediamine othercancer 26 µg/day (NSRL or MADL) Sub entry under "o-Phenylenediamine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
o-Phenylenediamine dihydrochlorideo-Phenylenediamine dihydrochloride othercancer 44 µg/day (NSRL or MADL) Sub entry under "o-Phenylenediamine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Phenyl glycidyl etherPhenyl glycidyl ether122-60-1 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
Phenyl glycidyl etherPhenyl glycidyl ether122-60-1 substancemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: April 4, 2014 | Shown in strikeout in the xlsx until 2014-04-04
Phenylhydrazine and its saltsPhenylhydrazine and its salts groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-07-01 | CAS column: "---"
PhenylhydrazinePhenylhydrazine othercancer 1 µg/day (NSRL or MADL) Sub entry under "Phenylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Phenylhydrazine hydrochloridePhenylhydrazine hydrochloride othercancer 1.4 µg/day (NSRL or MADL) Sub entry under "Phenylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
o-Phenylphenate, sodiumo-Phenylphenate, sodium132-27-4 substancecancer 200 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
o-Phenylphenolo-Phenylphenol90-43-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-08-04
Phenylphosphine [Basis for listing changed effective June 6, 2014]Phenylphosphine [Basis for listing changed effective June 6, 2014]638-21-1 substancedevelopmental male µg/day (NSRL or MADL) Listing mechanism: LC SQE; Date listed: 2009-08-07
PhiP(2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine)PhiP(2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine)105650-23-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
PimozidePimozide2062-78-4 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
PioglitazonePioglitazone111025-46-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2014-04-18
PipobromanPipobroman54-91-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
PirimicarbPirimicarb23103-98-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-07-01
PlicamycinPlicamycin18378-89-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Polybrominated biphenylsPolybrominated biphenyls othercancer 0.02 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01 | CAS column: "---"
Polybrominated biphenylsPolybrominated biphenyls otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01 | CAS column: "---"
Polychlorinated biphenylsPolychlorinated biphenyls othercancer 0.09 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---"
Polychlorinated biphenylsPolychlorinated biphenyls otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1991-01-01 | CAS column: "---"
Polychlorinated biphenyls (containing 60 or more percent chlorine by molecular weight)Polychlorinated biphenyls (containing 60 or more percent chlorine by molecular weight) othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01 | CAS column: "---"
Polychlorinated dibenzo-p-dioxinsPolychlorinated dibenzo-p-dioxins othercancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
Polychlorinated dibenzofuransPolychlorinated dibenzofurans othercancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
PolygeenanPolygeenan53973-98-1 substancecancer 1200 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Ponceau MXPonceau MX3761-53-3 substancecancer 200 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Ponceau 3RPonceau 3R3564-09-8 substancecancer 40 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Potassium bromatePotassium bromate7758-01-2 substancecancer 1 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Potassium dimethyldithiocarbamatePotassium dimethyldithiocarbamate128-03-0 substancedevelopmental 720 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
Pravastatin sodiumPravastatin sodium81131-70-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2000-03-03
Prednisolone sodium phosphatePrednisolone sodium phosphate125-02-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
PrimidonePrimidone125-33-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20
ProcarbazineProcarbazine671-16-9 substancecancer 0.05 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Procarbazine hydrochlorideProcarbazine hydrochloride366-70-1 substancecancer 0.06 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Procarbazine hydrochlorideProcarbazine hydrochloride366-70-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
ProcymidoneProcymidone32809-16-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
ProgesteroneProgesterone57-83-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
PronamidePronamide23950-58-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
PropachlorPropachlor1918-16-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-02-27
1,3-Propane sultone1,3-Propane sultone1120-71-4 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
PropargitePropargite2312-35-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
PropargitePropargite2312-35-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-06-15
PropazinePropazine139-40-2 substancedevelopmental, female 100 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-15
beta-Propiolactonebeta-Propiolactone57-57-8 substancecancer 0.05 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
PropoxurPropoxur114-26-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2006-08-11
Propylene glycol mono-t-butyl etherPropylene glycol mono-t-butyl ether57018-52-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2004-06-11
Propylene oxidePropylene oxide75-56-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
PropylthiouracilPropylthiouracil51-52-5 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
PropylthiouracilPropylthiouracil51-52-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
PulegonePulegone89-82-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2014-04-18
PymetrozinePymetrozine123312-89-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-03-22
PyridinePyridine110-86-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2002-05-17
PyrimethaminePyrimethamine58-14-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
QuazepamQuazepam36735-22-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
Quinoline and its strong acid saltsQuinoline and its strong acid salts groupcancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1997-10-24 | CAS column: "---"
Quizalofop-ethylQuizalofop-ethyl76578-14-8 substancemale 590 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-12-24
RadionuclidesRadionuclides othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01 | CAS column: "---"
ReserpineReserpine50-55-5 substancecancer 0.06 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Residual (heavy) fuel oilsResidual (heavy) fuel oils othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01 | CAS column: "---"
ResmethrinResmethrin10453-86-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-07-01
ResmethrinResmethrin10453-86-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.)Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.) otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01 | CAS column: "---"
RibavirinRibavirin36791-04-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
RibavirinRibavirin36791-04-5 substancemale µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
RiddelliineRiddelliine23246-96-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2004-12-03
RifampinRifampin13292-46-1 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
SaccharinSaccharin81-07-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: April 6, 2001 until 2001-04-06
Saccharin, sodiumSaccharin, sodium128-44-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01 | Delisted: January 17, 2003 until 2003-01-17
SafroleSafrole94-59-7 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Salted fish, Chinese-styleSalted fish, Chinese-style othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-04-29 | CAS column: "---"
Secobarbital sodiumSecobarbital sodium309-43-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
SedaxaneSedaxane874967-67-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-01
Selenium sulfideSelenium sulfide7446-34-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Sermorelin acetateSermorelin acetate otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20 | CAS column: "---"
Shale-oilsShale-oils68308-34-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-04-01
Silica, crystalline (airborne particles of respirable size)Silica, crystalline (airborne particles of respirable size) othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01 | CAS column: "---"
Silicon carbide whiskersSilicon carbide whiskers othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-11-17 | CAS column: "---"
SimazineSimazine122-34-9 substancedevelopmental, female 100 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-15
Sodium dimethyldithiocarbamateSodium dimethyldithiocarbamate128-04-1 substancedevelopmental 23 (oral) 58 (oral) as a 40% pesticidal formulation µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
Sodium fluoroacetateSodium fluoroacetate62-74-8 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils)Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils) othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---"
SpirodiclofenSpirodiclofen148477-71-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-10-08
SpironolactoneSpironolactone52-01-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-05-01
StanozololStanozolol10418-03-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-05-01
SterigmatocystinSterigmatocystin10048-13-2 substancecancer 0.02 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Streptomycin sulfateStreptomycin sulfate3810-74-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
Streptozocin (streptozotocin)Streptozocin (streptozotocin)18883-66-4 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
Streptozotocin (streptozocin)Streptozotocin (streptozocin)18883-66-4 substancecancer 0.006 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Strong inorganic acid mists containing sulfuric acidStrong inorganic acid mists containing sulfuric acid othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2003-03-14 | CAS column: "---"
StyreneStyrene100-42-5 substancecancer 27 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-04-22
Styrene oxideStyrene oxide96-09-3 substancecancer 4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
SulfallateSulfallate95-06-7 substancecancer 4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Sulfasalazine (Salicylazosulfapyridine)Sulfasalazine (Salicylazosulfapyridine)599-79-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Sulfasalazine (Salicylazosulfapyridine)Sulfasalazine (Salicylazosulfapyridine)599-79-1 substancemale µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
Sulfur dioxideeSulfur dioxidee7446-09-5 substancedevelopmental 10000 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2011-07-29
SulindacSulindac38194-50-2 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
TacrolimusTacrolimus104987-11-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2026-07-17
Talc containing asbestiform fibersTalc containing asbestiform fibers othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-04-01 | CAS column: "---"
Tamoxifen and its saltsTamoxifen and its salts10540-29-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1996-09-01
Tamoxifen citrateTamoxifen citrate54965-24-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
TemazepamTemazepam846-50-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
TeniposideTeniposide29767-20-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
TerbacilTerbacil5902-51-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-05-18
TeriparatideTeriparatide52232-67-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2015-08-14
TerrazoleTerrazole2593-15-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
Testosterone and its estersTestosterone and its esters58-22-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Testosterone cypionateTestosterone cypionate58-20-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-10-01
Testosterone enanthateTestosterone enanthate315-37-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Tetrabromobisphenol ATetrabromobisphenol A79-94-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2017-10-27
3,3',4,4'-Tetrachloroazobenzene3,3',4,4'-Tetrachloroazobenzene14047-09-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2012-07-24
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)1746-01-6 substancecancer 0.000005 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)1746-01-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1991-04-01
1,1,1,2-Tetrachloroethane1,1,1,2-Tetrachloroethane630-20-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2013-09-13
1,1,2,2-Tetrachloroethane1,1,2,2-Tetrachloroethane79-34-5 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
Tetrachloroethylene (Perchloroethylene)Tetrachloroethylene (Perchloroethylene)127-18-4 substancecancer 14 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
p-a,a,a-Tetrachlorotoluenep-a,a,a-Tetrachlorotoluene5216-25-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
TetrachlorvinphosTetrachlorvinphos22248-79-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2016-05-20
Tetracycline (internal use)Tetracycline (internal use)60-54-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-10-01
Tetracyclines (internal use)Tetracyclines (internal use) otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
Tetracycline hydrochloride (internal use)Tetracycline hydrochloride (internal use)64-75-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
TetrafluoroethyleneTetrafluoroethylene116-14-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-05-01
Δ9-Tetrahydrocannabinol (Δ9-THC)Δ9-Tetrahydrocannabinol (Δ9-THC) otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2020-01-03
TetrahydrofuranTetrahydrofuran109-99-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2021-12-17
TetranitromethaneTetranitromethane509-14-8 substancecancer 0.059 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
ThalidomideThalidomide50-35-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
ThioacetamideThioacetamide62-55-5 substancecancer 0.1 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
4,4'-Thiodianiline4,4'-Thiodianiline139-65-1 substancecancer 0.05 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
ThiodicarbThiodicarb59669-26-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20
ThioguanineThioguanine154-42-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Thiophanate methylThiophanate methyl23564-05-8 substancefemale, male 600 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-05-18
ThiouracilThiouracil141-90-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: ; Date listed: 2004-06-11
ThioureaThiourea62-56-6 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Thorium dioxideThorium dioxide1314-20-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Titanium dioxide (airborne, unbound particles of respirable size)Titanium dioxide (airborne, unbound particles of respirable size) othercancer 440 (diameters of 10 micrometers or less) 44 (diameters of 8 micrometers or less) µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-09-02 | CAS column: "---"
Tobacco, oral use of smokeless productsTobacco, oral use of smokeless products othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---"
Tobacco smokeTobacco smoke othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---"
Tobacco smoke (primary)Tobacco smoke (primary) otherdevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---"
Tobramycin sulfateTobramycin sulfate49842-07-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
TolueneToluene108-88-3 substancedevelopmental 7000 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1991-01-01 | c: toluene MADL footnote (absorbed dose; see list)
Toluene [Click here for the basis for the removal of female reproductive endpoint effective March 7, 2014]Toluene [Click here for the basis for the removal of female reproductive endpoint effective March 7, 2014]108-88-3 substancefemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07
Toluene diisocyanateToluene diisocyanate26471-62-5 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
o-Toluidineo-Toluidine95-53-4 substancecancer 4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
o-Toluidine hydrochlorideo-Toluidine hydrochloride636-21-5 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
para-Toluidinepara-Toluidine106-49-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | Delisted: October 29, 1999 until 1999-10-29
TopiramateTopiramate97240-79-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2015-11-27
Toxaphene (Polychlorinated camphenes)Toxaphene (Polychlorinated camphenes)8001-35-2 substancecancer 0.6 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Toxins derived from Fusarium moniliforme (Fusarium verticillioides)Toxins derived from Fusarium moniliforme (Fusarium verticillioides) othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | CAS column: "---"
TreosulfanTreosulfan299-75-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
TriadimefonTriadimefon43121-43-3 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
TriamtereneTriamterene396-01-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2014-04-18
TriazolamTriazolam28911-01-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF)S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF)78-48-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-02-25
Tributyltin methacrylateTributyltin methacrylate2155-70-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-12-01
Trichlormethine (Trimustine hydrochloride)Trichlormethine (Trimustine hydrochloride)817-09-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-01-01
Trichloroacetic acidTrichloroacetic acid76-03-9 substancecancer 9.9 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2013-09-13
1,1,1-Trichloroethane1,1,1-Trichloroethane71-55-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-04-21
TrichloroethyleneTrichloroethylene79-01-6 substancecancer 14 (oral) 50 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
TrichloroethyleneTrichloroethylene79-01-6 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2014-01-31
2,4,6-Trichlorophenol2,4,6-Trichlorophenol88-06-2 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
1,2,3-Trichloropropane1,2,3-Trichloropropane96-18-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-10-01
Trientine hydrochlorideTrientine hydrochloride38260-01-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
TriforineTriforine26644-46-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-06-18
1,3,5-Triglycidyl-s-triazinetrione1,3,5-Triglycidyl-s-triazinetrione2451-62-9 substancemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: December 13, 2013 until 2013-12-13
TrilostaneTrilostane13647-35-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
TrimethadioneTrimethadione127-48-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-01-01
2,4,5-Trimethylaniline and its strong acid salts2,4,5-Trimethylaniline and its strong acid salts groupcancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1997-10-24 | CAS column: "---"
Trimethylolpropane triacrylate, technical gradeTrimethylolpropane triacrylate, technical grade othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2021-12-17 | CAS column: "---"
Trimethyl phosphateTrimethyl phosphate512-56-1 substancecancer 24 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
Trimetrexate glucuronateTrimetrexate glucuronate82952-64-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
TRIM® VXTRIM® VX othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2018-05-25 | CAS column: "---"
2,4,6-Trinitrotoluene (TNT)2,4,6-Trinitrotoluene (TNT)118-96-7 substancecancer 8.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2008-12-19
Triphenyltin hydroxideTriphenyltin hydroxide76-87-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-07-01
Triphenyltin hydroxideTriphenyltin hydroxide76-87-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2002-03-18
Tris(aziridinyl)-p-benzoquinone (Triaziquone)Tris(aziridinyl)-p-benzoquinone (Triaziquone)68-76-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: December 8, 2006 until 2006-12-08
Tris(1-aziridinyl)phosphine sulfide (Thiotepa)Tris(1-aziridinyl)phosphine sulfide (Thiotepa)52-24-4 substancecancer 0.06 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Tris(2-chloroethyl) phosphateTris(2-chloroethyl) phosphate115-96-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-04-01
Tris(2,3-dibromopropyl)phosphateTris(2,3-dibromopropyl)phosphate126-72-7 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP)Tris(1,3-dichloro-2-propyl) phosphate (TDCPP)13674-87-8 substancecancer 5.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2011-10-28
Trp-P-1 (Tryptophan-P-1)Trp-P-1 (Tryptophan-P-1)62450-06-0 substancecancer 0.03 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Trp-P-2 (Tryptophan-P-2)Trp-P-2 (Tryptophan-P-2)62450-07-1 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Trypan blue (commercial grade)Trypan blue (commercial grade)72-57-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
Unleaded gasoline (wholly vaporized)Unleaded gasoline (wholly vaporized) othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---"
Uracil mustardUracil mustard66-75-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
Uracil mustardUracil mustard66-75-1 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
Urethane (Ethyl carbamate)Urethane (Ethyl carbamate)51-79-6 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Urethane (Ethyl carbamate)Urethane (Ethyl carbamate)51-79-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
UrofollitropinUrofollitropin97048-13-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Valproate (Valproic acid)Valproate (Valproic acid)99-66-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Vanadium pentoxide (orthorhombic crystalline form)Vanadium pentoxide (orthorhombic crystalline form)1314-62-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2005-02-11
Vinblastine sulfateVinblastine sulfate143-67-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Vinclozolin [basis for listing changed on November 16, 2006]Vinclozolin [basis for listing changed on November 16, 2006]50471-44-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-08-20
VinclozolinVinclozolin50471-44-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Vincristine sulfateVincristine sulfate2068-78-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Vinyl acetateVinyl acetate108-05-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2025-01-03
Vinyl bromideVinyl bromide593-60-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
Vinyl chlorideVinyl chloride75-01-4 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
4-Vinylcyclohexene4-Vinylcyclohexene100-40-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
4-Vinylcyclohexene [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013 ]4-Vinylcyclohexene [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013 ]100-40-3 substancefemale, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2009-08-07

Official source

Entries are copied exactly as published. Not legal advice; always check the official text.

2,437 SDSs. None left to chase.

NextSDS processes all 16 sections of every safety data sheet you receive and flags each product with a substance on Suggested substance list.

Get started todaySee how NextSDS works